The Journal of Cardiology and Cardiovascular Research (JCCR) is an independent scholarly peer-reviewed open access journal. The journal JCCR plays a vital role in monitoring advances in the vast fields of cardiovascular medicine, bringing collectively the results in a readable and lucid form. This wide perspective makes the Journal of Cardiology and Cardiovascular Research a unique information source for researchers, scientists, professors, and other clinical and health care professionals. Through open access it expands shared knowledge across doctors; it provides the free, immediate, availability of the published work online. This journal also involved into publishing news with time-by-time developments and advances in research of various Cardio-logical research advancements and their treatments.
We publish top-tier original research articles, letters, Perspectives, opinions, commentaries, case reports, letters to the editor, short communications, methodological clinical approaches, design, and goals of clinical trials, epidemiological studies, review articles, points of view, editorials, and Images of Cardiology and Cardiovascular Research. It covers the topics such as congestive heart failure, ischemic heart disease, cardiomyopathy, pharmacological and non-pharmacological treatment, valvular heart disease, vascular disease, cardiovascular biology, prosthetic devices, hypertension, arrhythmia, congenital heart disease, preventive cardiology, new diagnostic techniques, cardiovascular imaging, aneurysms, rheumatic heart disease, hypertensive heart disease, thromboembolic disease, acute myocardial infarction, atrial fibrillation, coronary artery disease, coronary disease, echocardiography, heart conditions, heart failure, stroke, ventricular arrhythmia and all sorts of cardiovascular disorders and clinical aspects.
Specializations of cardiology
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Journal Information
Area: cardiology and cardiovascular
Frequency: Quarterly
Language: English
Review Process: Double-blinded peer review process
Publication Timeline: 15 Days peer review process
Plagiarism Policy
The articles submitted by authors must contain a minimum of 80% unique content (Which should be unique and must not copy from any other web sites). The authors must maintain 100% uniqueness in the Results and conclusion part of the text. We will resend the articles, which have below 80% uniqueness to the authors for revision and asked for resubmissions with uniqueness (as per guidelines).
Author Benefits
Benefits of Open Access include greater visibility, accelerated citation, immediate access to the full-text versions, higher impact and authors retain the copyright to their work. All open access articles are published under the terms of the Creative Commons Attribution (CC-BY) license. It also allows immediate deposit of the final published version in other repositories without restriction on re-use.
Submit your manuscript through online or an e-mail: rubyeditor111@gmail.com
We encourage cardiologist, researchers, and other clinical and health professionals Worldwide to submit their manuscripts describing their original basic or clinical research findings and new diagnostic techniques to the Journal of Cardiology and Cardiovascular Research.
The following classifications and topics related to it will be considered for publication in the Journal of Cardiology and Cardiovascular Research but, not limited to the following fields
Discipline |
Object of study |
Level |
Expertise |
Clinical |
Blood |
Cellular |
Pharmacology |
Practical |
Vascular |
Subcellular |
Biochemistry |
Experimental |
Heart |
Multicellular |
Molecular biology |
Tissue |
Pathophysiology |
||
Organ |
Anatomy |
Key words
A | H | P |
Arrhythmia | Haemostasis | Prostaglandins |
Aortic valve | Haemoglobin | Protein kinases |
Anaesthesia | Heart failure | Pulmonary |
Angina | Heredity | Purkinje fibre |
Atrioventricular canal defect | High density lipoprotein (HDL) | Radionuclide imaging |
ACE inhibitors | Homocysteine | Pharmacokinetics |
Angiogenesis | Hormones | Rheumatic heart disease |
Anti-coagulants | I | Pericardiocentesis |
Acetyl choline | Ion channels | Paroxysmal supraventricular tachycardia (PSVT) |
Anti-arrhythmic agents | Immunology | R |
B | Ionotropic agents | Right ventricular assist device (RVAD) |
Blood flow | Infective endocarditis | Revascularization |
Bradycardia | Internal mammary artery | Regurgitation |
Beta blockers | Ischemic Heart | Renin angiotensin system |
Blood pressure | Disease | Repolarization |
Bacterial endocarditis | J | S |
C | Jugular veins | Saccular aneurysm |
Cardiology | K | Septal defect |
Carotid | K-channel | Shock |
Cardio vascular | K-ATP channel | Sphygmomanometer |
Contractile apparatus | L | Stem cells |
Ca blockers | Long QT syndrome | Stokes-Adams disease |
Cardioplegia | Lymphocytes | Streptokinase |
Collateral circulation | Liposomes | T |
Cell culture | M | Third-degree heart block |
Coronary disease | Maze surgery | Tamponade |
D | Magnetic resonance imaging (MRI) | Tachypnea |
Diabetes | Mitral stenosis | Thrombosis |
Defibrillation | Mortality | Thyroid |
E | Myocardial ischemia | Transient ischemic attack (TIA) |
ECG | Myocardial infarction | U |
Endothelial factors and function | Myxomatous degeneration | Ultrasound |
Epidemiology | N | V |
Endotoxins | Nitro glycerine | Valvuloplasty |
Echocardiogram | Necrosis | Vasopressors |
F | Neurotransmitters | Vertigo |
Fibrillation | Na/k channels | Varicose vein |
Free radicals | NMR | Valve replacement |
Fibrosis | O | W |
G | Open heart surgery | Wolff-Parkinson-White syndrome |
Glycolysis | Occluded artery | White blood cells |
Gene therapy | Obesity | |
Gene expressions | Oxidative phosphorylation | |
G-proteins | Oxygen consumption | |
G-coupling receptors | ||
Growth factors | ||
Medicine: J Cardiol Cardiovascular Res 2023, 5: 1
Medicine: J Cardiol Cardiovascular Res 2023, 5: 1
Medicine: J Cardiol Cardiovascular Res 2023, 5: 2
Medicine: J Cardiol Cardiovascular Res 2023, 5: 2
Medicine: J Cardiol Cardiovascular Res 2024, 6: 1
Medicine: J Cardiol Cardiovascular Res 2024, 6: 1
Medicine: J Cardiol Cardiovascular Res 2024, 6: 1
Medicine: J Cardiol Cardiovascular Res 2024, 6: 1
Medicine: J Cardiol Cardiovascular Res 2024, 6: 1
Medicine: J Cardiol Cardiovascular Res 2024, 6: 2
Medicine: J Cardiol Cardiovascular Res 2024, 6: 2
Medicine: J Cardiol Cardiovascular Res 2024, 6: 2
Medicine: J Cardiol Cardiovascular Res 2024, 6: 2
Medicine: J Cardiol Cardiovascular Res 2024, 6: 2